CivaTech

https://www.businesswire.com/news/home/20210830005509/en/Cancer-Experts-Report-Initial-Findings-of-CivaSheet%C2%AE-Soft-Tissue-Sarcoma-Registry

Cancer Experts Report Initial Findings of CivaSheet® Soft Tissue Sarcoma Registry Physicians from four medical centers recently published data this month from an initial six patients implanted with CivaSheet® to treat retroperitonea

CivaTech Oncology, Inc. is advancing treatment with our uni-directional CivaSheet. CivaSheet has 100% local control for resectable patients implanted at the time of surgery. We are proud to be spotlighted in this tribute to Alex Trebek and hope his death will bring awareness to this disease.

Alex Trebek's death shines light on pancreatic cancer research being done in Triangle to enhance treatment Alex Trebek's death 18 months after a pancreatic cancer diagnosis comes as Triangle companies continue research on enhancing treatment of the disease.

https://www.businesswire.com/news/home/20201027005681/en/CivaTech-Oncology-and-NYU-Langone-Health-Launch-NIH-sponsored-Trial-to-Fight-Lung-Cancer

CivaTech Oncology and NYU Langone Health Launch NIH-sponsored Trial to Fight Lung Cancer Physicians from NYU Langone Health and its Perlmutter Cancer Center successfully treated their first patient in an NIH/NCI- sponsored clinical trial u

CivaTech Oncology Press Release - Pancreatic Cancer

http://www.businesswire.com/news/home/20170523005909/en/CivaTech-Oncology-%C2%AE-Offers-Technology-Fight-Pancreatic

CivaTech Oncology Inc. ® Offers New Technology to Fight Pancreatic Cancer Physicians at VCU Massey Cancer Center in Richmond, VA are first in the world to implant a new bio-absorbable, unidirectional radiation treatment know